GHCongressional Stock Trades
Guardant Health, Inc. Common Stock
Services-Medical Laboratories
Congressional stock trades in Guardant Health, Inc. Common Stock (GH) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
2
Politicians Trading
2
Last Traded
Sep 28, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Jonathan L. JacksonD | Oct 19, 2026 | Sep 28, 2026 | Buy | $15,001 - $50,000 | -1.31% |
| Sheldon WhitehouseD | Dec 1, 2025 | Nov 21, 2025 | Buy | $1,001 - $15,000 | +66.00% |
Price History
About Guardant Health, Inc. Common Stock
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
2 members of Congress have disclosed 2 trades in Guardant Health, Inc. Common Stock (GH). Most active: Jonathan L. Jackson (1), Sheldon Whitehouse (1).
Across all disclosures, members of Congress reported 2 purchases and 0 sales of Guardant Health, Inc. Common Stock (GH). The most recent trade was on Sep 28, 2026.
Jonathan L. Jackson disclosed buying Guardant Health, Inc. Common Stock (GH) on Sep 28, 2026, valued at $15,001 - $50,000.
From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.